Aethlon Medical Inc

Discover how San Diego‑based Aethlon Medical is pioneering blood‑stream particle removal to tackle cancer and infectious disease, and what this means for investors and patient care.

Discover how Aethlon Medical’s innovative device technology targets life‑threatening particles while navigating volatile stock performance and future financial outlook.

Aethlon Medical, Inc. is a pioneering medical device company dedicated to addressing life-threatening conditions through innovative technologies, despite facing financial challenges in the health care sector.

Aethlon Medical, Inc. is a pioneering force in medical device technology, dedicated to revolutionizing the treatment of life-threatening conditions through innovative solutions for cancer and infectious diseases.

Aethlon Medical, a medical device company, is set to release its quarterly earnings on June 26, 2025, with analysts expecting a loss of $1.073 per share for the quarter.